CH-Bioforce helps world’s biggest brewing company turn brewing waste into textiles
CH-Bioforce has been chosen for AB InBev´s global start-up accelerator programme, 100+Accelerator.
Solutions for some of the most pressing environmental challenges of our time
The world’s biggest brewing company, AB InBev, manufacturer of brands like Budweiser, Beck’s and Corona, generates millions of tons of co-product every year. The multinational company is now looking for new, sustainable solutions to put the waste streams into use. CH-Bioforce is one of the 17 international start-ups that have been chosen to be part of the second cohort of the 100+Accelerator.
Brewing waste like barley straw or brewer’s spent grain can be repurposed into other types of consumer products for food products or even as ingredients in cosmetics or pharmaceuticals. Packaging solutions are another option.
CH-Bioforce has been able to develop a breakthrough biomass fractionation technology which can use almost any kind of lignocellulosic biomass as feedstock. In 100+Accelerator, CH-Bioforce fractionates the barley straw delivered by AB InBev and works with chosen partners to make high-quality textiles.
From waste to well-being – six months of research and development
AB InBev’s accelerator programme lasts six months. CH-Bioforce will use this period to refine technology that produces high-quality biopolymers – pulp, hemicellulose and lignin. These materials can replace oil and food-based materials in multiple applications.
CH-Bioforce’s high-purity pulp can be refined into textiles. The end product could be a T-shirt, towel or a shopping bag. The technology is already in place and fully functional.
The brewing process produces also other biomass waste streams in addition to straw, such as brewer’s spent grain. These can be used to produce high-quality biopolymers, which can then be used in the production of plastics, cosmetics or even food additives.
Read more: 100+Accelerator
CH-Bioforce Oy is a Finnish start-up founded in 2016. The company’s innovative fractionation technology dates back to 2011, when inventors Lari Vähäsalo, Nicholas Lax and Sebastian von Schoultz made their first findings. Today, the company forms part of the Chemec group, which operates in the chemical industry. CH-Bioforce currently employs ten members of staff. Our R&D and pilot plant is located in Raisio, Finland.
For more information, please contact:
Lari Vähäsalo, PhD
R&D Director, CH-Bioforce Oy
- +358 40 351 2820